These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7789746)

  • 1. Effect of induced metamorphosis on the immune system of the axolotl, Ambystoma mexicanum.
    Ussing AP; Rosenkilde P
    Gen Comp Endocrinol; 1995 Mar; 97(3):308-19. PubMed ID: 7789746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low submetamorphic doses of dexamethasone and thyroxine induce complete metamorphosis in the axolotl (Ambystoma mexicanum) when injected together.
    Kühn ER; De Groef B; Grommen SV; Van der Geyten S; Darras VM
    Gen Comp Endocrinol; 2004 Jun; 137(2):141-7. PubMed ID: 15158126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroxine and triiodothyronine in plasma and thyroids of the neotenic and metamorphosed axolotl Ambystoma mexicanum: influence of TRH injections.
    Jacobs GF; Michielsen RP; Kühn ER
    Gen Comp Endocrinol; 1988 Apr; 70(1):145-51. PubMed ID: 3131185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroxine-induced metamorphosis in the axolotl (Ambystoma mexicanum).
    Coots PS; Seifert AW
    Methods Mol Biol; 2015; 1290():141-5. PubMed ID: 25740483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone-mediated metamorphosis in the neotenic axolotl Ambystoma mexicanum: synergistic involvement of thyroxine and corticoids on brain type II deiodinase.
    Kühn ER; De Groef B; Van der Geyten S; Darras VM
    Gen Comp Endocrinol; 2005 Aug; 143(1):75-81. PubMed ID: 15993107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of protein expression profile of limb regeneration between neotenic and metamorphic axolotl.
    Sibai M; Altuntaş E; Süzek BE; Şahin B; Parlayan C; Öztürk G; Baykal AT; Demircan T
    Biochem Biophys Res Commun; 2020 Feb; 522(2):428-434. PubMed ID: 31767146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference of the in vivo responsiveness to thyrotropin stimulation between the neotenic and metamorphosed axolotl, Ambystoma mexicanum: failure of prolactin to block the thyrotropin-induced thyroxine release.
    Darras VM; Kühn ER
    Gen Comp Endocrinol; 1984 Nov; 56(2):321-5. PubMed ID: 6510692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of the axolotl cell landscape using combinatorial hybridization sequencing at single-cell resolution.
    Ye F; Zhang G; E W; Chen H; Yu C; Yang L; Fu Y; Li J; Fu S; Sun Z; Fei L; Guo Q; Wang J; Xiao Y; Wang X; Zhang P; Ma L; Ge D; Xu S; Caballero-Pérez J; Cruz-Ramírez A; Zhou Y; Chen M; Fei JF; Han X; Guo G
    Nat Commun; 2022 Jul; 13(1):4228. PubMed ID: 35869072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pigmentary system of developing axolotls. I. A biochemical and structural analysis of chromatophores in wild-type axolotls.
    Frost SK; Epp LG; Robinson SJ
    J Embryol Exp Morphol; 1984 Jun; 81():105-25. PubMed ID: 6470605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A histological atlas of the tissues and organs of neotenic and metamorphosed axolotl.
    Demircan T; İlhan AE; Aytürk N; Yıldırım B; Öztürk G; Keskin İ
    Acta Histochem; 2016 Sep; 118(7):746-759. PubMed ID: 27436816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimentally induced metamorphosis in highly regenerative axolotl (ambystoma mexicanum) under constant diet restructures microbiota.
    Demircan T; Ovezmyradov G; Yıldırım B; Keskin İ; İlhan AE; Fesçioğlu EC; Öztürk G; Yıldırım S
    Sci Rep; 2018 Jul; 8(1):10974. PubMed ID: 30030457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of spontaneous and corticosteroid-induced apoptosis of lymphocyte populations from metamorphosing frogs/RU486 inhibition.
    Barker KS; Davis AT; Li B; Rollins-Smith LA
    Brain Behav Immun; 1997 Jun; 11(2):119-31. PubMed ID: 9299061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexamethasone treatment on iodothyronine deiodinase activities and on metamorphosis-related morphological changes in the axolotl (Ambystoma mexicanum).
    Darras VM; Van der Geyten S; Cox C; Segers IB; De Groef B; Kühn ER
    Gen Comp Endocrinol; 2002 Jun; 127(2):157-64. PubMed ID: 12383443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in brain gangliosides of the neotene and metamorphic (thyroxine-induced) newt axolotl (Ambystoma mexicanum).
    Hilbig R; Schmitt M; Rahmann H
    Dev Neurosci; 1987; 9(4):240-6. PubMed ID: 3428191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model of transcriptional and morphological changes during thyroid hormone-induced metamorphosis of the axolotl.
    Page RB; Monaghan JR; Walker JA; Voss SR
    Gen Comp Endocrinol; 2009 Jun; 162(2):219-32. PubMed ID: 19275901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fiber counts of regenerating peripheral nerves in axolotls and the effect of metamorphosis.
    Ehrlich D; Mark RF
    J Comp Neurol; 1977 Jul; 174(2):307-16. PubMed ID: 864039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme clusters during the metamorphic period of Ambystoma mexicanum: role of thyroid hormone.
    Lamers WH; Mooren PG; de Graaf A
    J Exp Zool; 1982 Oct; 223(2):123-32. PubMed ID: 6128371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary genetics of metamorphic failure using wild-caught vs. laboratory axolotls (Ambystoma mexicanum).
    Voss SR; Shaffer HB
    Mol Ecol; 2000 Sep; 9(9):1401-7. PubMed ID: 10972778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized axolotl (Ambystoma mexicanum) husbandry, breeding, metamorphosis, transgenesis and tamoxifen-mediated recombination.
    Khattak S; Murawala P; Andreas H; Kappert V; Schuez M; Sandoval-Guzmán T; Crawford K; Tanaka EM
    Nat Protoc; 2014 Mar; 9(3):529-40. PubMed ID: 24504478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of 3,5-T2 and T3 on the gill regeneration and metamorphosis of the
    Lazcano I; Olvera A; Pech-Pool SM; Sachs L; Buisine N; Orozco A
    Front Endocrinol (Lausanne); 2023; 14():1208182. PubMed ID: 37492199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.